Large study finds ‘no evidence’ anti-malarials benefit Covid-19 patients  

The anti-malarial treatments chloroquine and hydroxychloroquine do not provide benefit to Covid-19 patients, according to researchers from the US and Switzerland. In fact, their study found the use of chloroquine or hydroxychloroquine was linked to increased rates of mortality and heart arrhythmias among hospital patients…

The post Large study finds ‘no evidence’ anti-malarials benefit Covid-19 patients   appeared first on Nursing Times.



Reactions:

0 comments:

Post a comment